Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03069924 · ClinicalTrials.gov registry record · Phase 2
Gain-framed Messages and NRT for Lung Cancer Screening Patients
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 367
- Enrollment target
NCT03069924 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 367 participants.
The verdict
NCT03069924, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 367 participants
- Enrollment target
Study Summary
This research is a randomized smoking cessation trial conducted within and specifically personalized for lung cancer screening patients presenting to a lung screening clinic. Novel tobacco treatments for this population are critically needed, given the growing population of lung screening patients, which will grow dramatically now that lung screening is an approved CMS benefit. In the proposed study, we will test a gain-framed messaging intervention specifically designed for lung screening patients (vs. unframed messaging), as well as evaluating NRT sampling (vs. no medication) at 2 study sites. Our project is designed to be translational (in that it can be transferable from our controlled efficacy study to other lung screening programs).
Interventions
- BEHAVIORAL Gain-framed messaging
- COMBINATION_PRODUCT Unframed messaging materials
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 367 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2024-08-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03069924
The ClinicalTrials.gov registry entry for NCT03069924 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 367 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Gain-framed messaging is the first listed.
NCT03069924 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03069924 about?
NCT03069924 is a clinical study titled "Gain-framed Messages and NRT for Lung Cancer Screening Patients". This research is a randomized smoking cessation trial conducted within and specifically personalized for lung cancer screening patients presenting to a lung screening clinic. Novel tobacco treatments for this population are critically needed, given the growing population of lung screening patients, ...
What is the current status of trial NCT03069924?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 367 participants. The study started on 2017-07-01. Estimated completion is 2024-08-10.
What interventions are being tested in trial NCT03069924?
The interventions under investigation include: Gain-framed messaging (BEHAVIORAL), Unframed messaging materials (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03069924?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.